Insider Transactions in Q2 2023 at Greenwich Life Sciences, Inc. (GLSI)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$11,000
$11.69 P/Share
|
|
Apr 28
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
250
+0.1%
|
$2,750
$11.22 P/Share
|
|
Apr 19
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
7,000
+0.13%
|
$77,000
$11.1 P/Share
|
|
Apr 18
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.04%
|
$22,000
$11.12 P/Share
|
|
Apr 11
2023
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
1,000
+0.39%
|
$11,000
$11.87 P/Share
|
|
Apr 11
2023
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.09%
|
$60,000
$12.42 P/Share
|